<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00539370</url>
  </required_header>
  <id_info>
    <org_study_id>070213</org_study_id>
    <secondary_id>07-EI-0213</secondary_id>
    <nct_id>NCT00539370</nct_id>
  </id_info>
  <brief_title>Human Samples and Data Repository</brief_title>
  <official_title>Laboratory of Immunology/National Eye Institute Repository</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Eye Institute (NEI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      This protocol will enable IRB (institutional review board) review of proposed research using&#xD;
      human samples and data collected under the terminated NIH studies 04-EI-0065 and 96-EI-0096.&#xD;
      Data and samples may include demographic and personal health information, psychological or&#xD;
      psychiatric testing, blood, urine, CSF or other body fluids or tissues and results of medical&#xD;
      and physiological evaluation and medical imaging.&#xD;
&#xD;
      Data and sample analyses are limited to those approved under the original protocols unless&#xD;
      additional specific institutional review board approval is obtained.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: This protocol will enable prospective IRB review of research using human samples&#xD;
      and data collected under other branch protocols.&#xD;
&#xD;
      Study population: Participants that were followed in terminated branch protocols under which&#xD;
      data or samples were collected.&#xD;
&#xD;
      Design: Samples and data will be brought under this protocol, analyzed and stored for uses&#xD;
      specified in the original protocols and as additionally approved by the IRB.&#xD;
&#xD;
      Outcome: The outcome of this protocol will be the storage, tracking, and utilization of&#xD;
      samples and data obtained under terminated protocols.&#xD;
&#xD;
      Purpose: The purpose of this protocol is to enable prospective IRB review of research using&#xD;
      human samples and data collected under other branch protocols.&#xD;
&#xD;
      Participants: Participants who previously participated in NIH protocols whose wishes&#xD;
      regarding use of their samples or data for research other than that specified in the initial&#xD;
      protocol is not known may be enrolled in this protocol. At this time, there are no additional&#xD;
      analyses planned outside of the original protocols, apart from those listed below.&#xD;
      Participant consent or IRB approval for a waiver of additional informed consent will be&#xD;
      sought prior to initiation of additional analyses.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 29, 2007</start_date>
  <completion_date type="Actual">May 23, 2017</completion_date>
  <primary_completion_date type="Actual">May 23, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">4659</enrollment>
  <condition>Uveitis</condition>
  <condition>Scleritis</condition>
  <eligibility>
    <criteria>
      <textblock>
        -  Data Analysis Study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hatice N Sen, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Eye Institute (NEI)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center, 9000 Rockville Pike</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://clinicalstudies.info.nih.gov/cgi/detail.cgi?B_2007-EI-0213.html</url>
    <description>NIH Clinical Center Detailed Web Page</description>
  </link>
  <verification_date>June 2016</verification_date>
  <study_first_submitted>October 3, 2007</study_first_submitted>
  <study_first_submitted_qc>October 3, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 4, 2007</study_first_posted>
  <last_update_submitted>March 18, 2021</last_update_submitted>
  <last_update_submitted_qc>March 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Scleritis</keyword>
  <keyword>Intermediate Uveitis</keyword>
  <keyword>Posterior Uveitis</keyword>
  <keyword>Intraocular Inflammatory Disease</keyword>
  <keyword>Data Analysis</keyword>
  <keyword>Data Collection</keyword>
  <keyword>Sample Analysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uveitis</mesh_term>
    <mesh_term>Scleritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

